JACOBS LEVY EQUITY MANAGEMENT, INC

Position in DNA — Ginkgo Bioworks Holdings, Inc.

CIK 884414 FLORHAM PARK, NJ

Position in DNA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$609,078

-$1,369,177 QoQ

Shares Held

61,461

-81.0% QoQ

Ownership

0.091%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#57

of 183 holders

Holding Since

Mar 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names. DNA ranks #64 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	256,503	$159,939,880
2	RARE	Ultragenyx Pharmaceutical Inc.	2,939,719	$98,157,217
3	INCY	Incyte Corp	731,774	$82,953,900
4	CORT	Corcept Therapeutics Inc	695,532	$60,476,507
5	HALO	Halozyme Therapeutics, Inc.	322,377	$25,232,447
6	EXEL	Exelixis, Inc.	415,650	$22,615,516
7	AUPH	Aurinia Pharmaceuticals Inc.	1,231,516	$20,898,826
8	ALNY	Alnylam Pharmaceuticals, Inc.	60,986	$18,358,615

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$609,078	61,461	-81.0%	Shares	Sole	2026-08-14
2026-03-31	$1,978,255	322,717	+32.0%	Shares	Sole	2026-05-15
2025-12-31	$2,031,121	244,419	+244.9%	Shares	Sole	2026-02-13
2025-09-30	$1,033,240	70,867	-74.7%	Shares	Sole	2025-11-17
2024-09-30	$2,281,625	279,954	+9.2%	Shares	Sole	2024-11-14
2023-12-31	$433,147	256,300	0.0%	Shares	Sole	2024-02-14
2023-09-30	$463,903	256,300	-93.1%	Shares	Sole	2023-11-17
2023-06-30	$6,919,300	3,720,054	-45.0%	Shares	Sole	2023-08-14
2023-03-31	$8,994,800	6,763,008	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.